Loading company…
Tearscience develops products and technology to help eye care professionals treat Meibomian Gland Dysfunction.
Tearscience develops ocular health technology focused on Meibomian Gland Dysfunction and related eye conditions. Its TearScience technology helps eye care professionals assess and manage ocular surface issues, including discomfort associated with contact lenses. The company was established in 2005 and is based in Morrisville, US. It raised USD 19.23 mn in Series D funding, with Essex Woodlands as its latest investor.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in